JPRN-UMIN000005775已完成未知
Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance. - Assessment of efficacy and safety of ezetimibe in patients with dyslipidemia complicated insulin resistance.
The Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University Hospital0 个研究点目标入组 47 人开始时间: 2011年6月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)HbA1c>=8% 2)Patients with anamnesis for anaphylaxis of ezetimibe tablets 3)Complicated with Severe renal and/or hepatic disease 4)Having anamnesis of myocardial infarction, angina and/or stroke 5)Patients with secondary hyperlipidemia or drug-associated hyperlipidemia 6)Patients who are pregnant or lactating women and women suspected of being pregnant 7)Patients of Familial hyperlipidemia 8)Other patients deemed not appropriate for study entry by the investigator.
研究者
相似试验
进行中（未招募）
不适用
Efficacy, safety, and tolerability of ezetimibe in coadministration with simvastin in the therapy of adolescent with heterozygous familial hypercholesterolemiaTherapy of adolescents with etherozygous familial hypercholesterolemiaMedDRA version: 6.1Level: PTClassification code 10020603EUCTR2004-002627-40-ITSCHERING-PLOUGH
进行中（未招募）
1 期
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyAdolescent (age >=10 and <=17 years) subjects with Heterozygous Familial Hypercholesterolemia (HeFH).MedDRA version: 7.0 Level: LLT Classification code 10057099EUCTR2004-002627-40-ESSchering-Plough Research Institute248
进行中（未招募）
不适用
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyAdolescent (age >=10 and <=17 years) subjects with Heterozygous Familial Hypercholesterolemia (HeFH).MedDRA version: 7.0Level: LLTClassification code 10057099EUCTR2004-002627-40-ATSchering-Plough Research Institute210
进行中（未招募）
不适用
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyEUCTR2004-002627-40-DESchering-Plough Research Institute on behalf of MSP Singapore Company, LLC210
进行中（未招募）
1 期
Efficacy, Safety, and Tolerability of Ezetimibe in Coadministration With Simvastatin in the Therapy of Adolescents With Heterozygous Familial Hypercholesterolemia - Pediatric HeFH StudyEUCTR2004-002627-40-FISchering-Plough Research Institute248